ArticleFrontiers in immunology2022

The Outcome of Induction Therapy for EBV-Related Hemophagocytic Lymphohistiocytosis: A Model for Risk Stratification.

Tingting Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.